- Home
- GNS vs NXL Comparison
GNS vs NXL Comparison
Compare GNS & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNS
- NXL
- Stock Information
- Founded
- GNS 2002
- NXL 2010
- Country
- GNS Singapore
- NXL United States
- Employees
- GNS N/A
- NXL N/A
- Industry
- GNS Other Consumer Services
- NXL Medical Specialities
- Sector
- GNS Real Estate
- NXL Health Care
- Exchange
- GNS Nasdaq
- NXL Nasdaq
- Market Cap
- GNS 17.8M
- NXL 21.0M
- IPO Year
- GNS 2022
- NXL 2022
- Fundamental
- Price
- GNS $1.32
- NXL $0.92
- Analyst Decision
- GNS
- NXL Strong Buy
- Analyst Count
- GNS 0
- NXL 1
- Target Price
- GNS N/A
- NXL $5.00
- AVG Volume (30 Days)
- GNS 13.0M
- NXL 95.0K
- Earning Date
- GNS 04-30-2025
- NXL 08-07-2025
- Dividend Yield
- GNS N/A
- NXL N/A
- EPS Growth
- GNS N/A
- NXL N/A
- EPS
- GNS N/A
- NXL N/A
- Revenue
- GNS $7,912,718.00
- NXL $131,065.00
- Revenue This Year
- GNS $233.65
- NXL $79.59
- Revenue Next Year
- GNS $570.20
- NXL $334.65
- P/E Ratio
- GNS N/A
- NXL N/A
- Revenue Growth
- GNS N/A
- NXL N/A
- 52 Week Low
- GNS $0.21
- NXL $0.59
- 52 Week High
- GNS $3.20
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- GNS 89.26
- NXL 28.61
- Support Level
- GNS $0.34
- NXL $1.12
- Resistance Level
- GNS $0.71
- NXL $1.12
- Average True Range (ATR)
- GNS 0.14
- NXL 0.09
- MACD
- GNS 0.07
- NXL -0.01
- Stochastic Oscillator
- GNS 83.51
- NXL 20.91
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.